See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Georges Jourdi

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	40103262	0	Mokhtarian A, Melicine S, Siguret V, et al. Effect of Selective Serotonin Reuptake Inhibitors on Coagulation: Fact or Fiction? Clin Transl Sci. 2025 Mar;18(3):e70164. doi: 10.1111/cts.70164.
	38729577	0	Schreuder M, Jourdi G, Veizaj D, et al. Minimally Modified Human Blood Coagulation Factor X to Bypass Direct Factor Xa Inhibitors. J Thromb Haemost. 2024 May 8:S1538-7836(24)00254-X. doi: 10.1016/j.jtha.2024.04.022.
	38706782	0	Boukhatem I, Fleury S, Jourdi G, et al. The intriguing role of platelets as custodians of brain-derived neurotrophic factor. Res Pract Thromb Haemost. 2024 Apr 3;8(3):102398. doi: 10.1016/j.rpth.2024.102398. eCollection 2024 Mar.
	38011218	0	Larreche S, Chevillard L, Jourdi G, et al. Bothrops venom-induced hemostasis disorders in the rat: Between Scylla and Charybdis. PLoS Negl Trop Dis. 2023 Nov 27;17(11):e0011786. doi: 10.1371/journal.pntd.0011786.
	37888645	0	Larreche S, Bousquet A, Chevillard L, et al. Bothrops atrox and Bothrops lanceolatus Venoms In Vitro Investigation: Composition, Procoagulant Effects, Co-Factor Dependency, and Correction Using Antivenoms. Toxins (Basel). 2023 Oct 16;15(10):614. doi: 10.3390/toxins15100614.
	37481072	0	Jourdi G, Ramstrom S, Sharma R, et al. Consensus report on flow cytometry for platelet function testing in thrombocytopenic patients: communication from the SSC of the ISTH. J Thromb Haemost. 2023 Jul 20:S1538-7836(23)00564-0. doi: 10.1016/j.jtha.2023.07.006.
	36395818	0	Foulon-Pinto G, Lafuente-Lafuente C, Jourdi G, et al. Assessment of DOAC in GEriatrics (Adage Study): Rivaroxaban/Apixaban Concentrations and Thrombin Generation Profiles in NVAF Very Elderly Patients. Thromb Haemost. 2023 Apr;123(4):402-414. doi: 10.1055/a-1981-1763. Epub 2022 Nov 17.
	35386738	0	Furtado S, Dunogue B, Jourdi G, et al. High D-dimer plasma concentration in systemic sclerosis patients: Prevalence and association with vascular complications. J Scleroderma Relat Disord. 2021 Jun;6(2):178-186. doi: 10.1177/2397198320957558. Epub 2020 Sep 24.
	35008518	0	Carre J, Jourdi G, Gendron N, et al. Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome. Int J Mol Sci. 2021 Dec 22;23(1). pii: ijms23010093. doi: 10.3390/ijms23010093.
	34884884	0	Jourdi G, Lordkipanidze M, Philippe A, et al. Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases. Int J Mol Sci. 2021 Dec 3;22(23). pii: ijms222313079. doi: 10.3390/ijms222313079.
	34126147	0	Jourdi G, Abdoul J, Siguret V, et al. Induced forms of alpha2-macroglobulin neutralize heparin and direct oral anticoagulant effects. Int J Biol Macromol. 2021 Aug 1;184:209-217. doi: 10.1016/j.ijbiomac.2021.06.058. Epub 2021 Jun 11.
	33881229	0	Gendron N, Dragon-Durey MA, Chocron R, et al. Lupus Anticoagulant Single Positivity During the Acute Phase of COVID-19 Is Not Associated With Venous Thromboembolism or In-Hospital Mortality. Arthritis Rheumatol. 2021 Nov;73(11):1976-1985. doi: 10.1002/art.41777. Epub 2021 Sep 22.
	33449299	0	Philippe A, Chocron R, Gendron N, et al. Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis. 2021 Aug;24(3):505-517. doi: 10.1007/s10456-020-09762-6. Epub 2021 Jan 15.
	33369212	0	Foulon-Pinto G, Jourdi G, Perrin J, et al. Study of thrombin generation with St Genesia to evaluate xaban pharmacodynamics: Analytical performances over 18 months. Int J Lab Hematol. 2021 Aug;43(4):821-830. doi: 10.1111/ijlh.13443. Epub 2020 Dec 28.
	33249076	0	Atsou S, Furlan F, Duchemin J, et al. Pharmacodynamics of eftrenonacog-alfa (rFIX-Fc) in severe hemophilia B patients: A real-life study. Eur J Pharmacol. 2021 Jan 15;891:173764. doi: 10.1016/j.ejphar.2020.173764. Epub 2020 Nov 27.
	32932543	0	Jourdi G, Lobies S, Kosmider O, et al. Coagulation Characterization of Prothrombin 20209C > T Variant: About 27 New Cases. Thromb Haemost. 2021 Feb;121(2):246-249. doi: 10.1055/s-0040-1716541. Epub 2020 Sep 15.
	31710863	0	Jourdi G, Delrue M, Stepanian A, et al. Potential usefulness of activated charcoal (DOAC remove(R)) for dRVVT testing in patients receiving Direct Oral AntiCoagulants. Thromb Res. 2019 Dec;184:86-91. doi: 10.1016/j.thromres.2019.11.001. Epub 2019 Nov 5.
	31487115	0	Gay J, Duchemin J, Imarazene M, et al. Lupus anticoagulant diagnosis in patients receiving direct oral FXa inhibitors at trough levels: A real-life study. Int J Lab Hematol. 2019 Dec;41(6):738-744. doi: 10.1111/ijlh.13101. Epub 2019 Sep 5.
	30591426	0	Jourdi G, Le Bonniec B, Gouin-Thibault I. Strategies of neutralization of the direct oral anticoagulants effect: review of the literature. Ann Biol Clin (Paris). 2019 Feb 1;77(1):67-78. doi: 10.1684/abc.2018.1400.
	30507843	0	Gkalea V, Khaterchi A, Levy P, et al. Prospective Evaluation of a Rapid Functional Assay for Heparin-Induced Thrombocytopenia Diagnosis in Critically Ill Patients. Crit Care Med. 2019 Mar;47(3):353-359. doi: 10.1097/CCM.0000000000003574.
	30308522	0	Pailleret C, Jourdi G, Siguret V, et al. Modified ROTEM for the detection of rivaroxaban and apixaban anticoagulant activity in whole blood: A diagnostic test study. Eur J Anaesthesiol. 2019 Jun;36(6):449-456. doi: 10.1097/EJA.0000000000000903.
	30071567	0	Jourdi G, Gouin-Thibault I, Siguret V, et al. FXa-alpha2-Macroglobulin Complex Neutralizes Direct Oral Anticoagulants Targeting FXa In Vitro and In Vivo. Thromb Haemost. 2018 Sep;118(9):1535-1544. doi: 10.1055/s-0038-1667014. Epub 2018 Aug 2.
	29626988	0	Jourdi G, Lefebvre S, Le Bonniec B, et al. Thrombin generation test: A reliable tool to evaluate the pharmacodynamics of vitamin K antagonist rodenticides in rats. Pestic Biochem Physiol. 2018 Apr;146:19-24. doi: 10.1016/j.pestbp.2018.02.004. Epub 2018 Feb 15.
	25761505	0	Jourdi G, Siguret V, Martin AC, et al. Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxaban. Thromb Haemost. 2015 Jul;114(1):78-86. doi: 10.1160/TH14-10-0877. Epub 2015 Mar 12.